Meridian rapid colitis test:
This article was originally published in Clinica
Executive Summary
The US FDA has cleared for sale Meridian Bioscience's rapid new test for diagnosing a major cause of antibiotic-associated colitis. The ImmunoCard Toxins A&B test detects the most important toxins produced by strains of the Clostridium difficile bacterium. By producing a colour-change result in just minutes, the test allows for a rapid "test and treat" response following symptoms, said the Cincinnati, Ohio firm.